With the emergence of the Corona epidemic and causing blood clots to some patients, doctors gave serious cases in hospitals, anticoagulant drugs, but now the American Safety Committee has found, that high doses may sometimes harm more than good.
A number of countries led international experiments to examine the effectiveness of blood coagulants on Corona patients, but this week it was announced that the trial for Corona patients who are in critical conditions in hospital was temporarily stopped, because there does not seem to be any benefit from the treatment and there may be some harm.
Stop testing blood thinners –
The American Independent Monitoring Authority did not announce, according to a newspaper report. nytimesWhat called for the trial to be paused, what potential harms it found, but it is known that high doses of anticoagulants cause uncontrollable bleeding – in places including inside the skull, which can be very dangerous.
The trial leaders are urgently trying to publish an announcement that the trial has been temporarily stopped, as some hospitals are still placing intensive care patients with high doses of anticoagulants in the belief that the benefits outweigh the risks, while the opposite may be true.
“We need to publicize this pause in the trial widely because of the potential for harm,” said Dr. Matthew Neal, a surgeon and intensive care specialist at the University of Pittsburgh Medical Center, USA, who leads one of the center’s many teams.
The teams participating in the trial, which included nearly 3,000 patients in several countries, will closely examine the data to see if enrollment in the hospital branch of the trial focused on critically ill patients can start again.
It is widely known that the Corona virus, causes clumps of small blood clots that can block capillaries and cause damage to the lungs, kidneys, heart, brain or other organs, even in the fingers and toes.
And in October, an observational study in the Journal of the American College of Cardiology found that hospitalized Corona patients who were given blood thinners achieved much better results than those who did not get any, and in that study, there was little difference in the results or Negative side effects among those who received low or high doses.
Anticoagulants are known to cause bleeding under the skin and inside the digestive system, and wounds that do not heal when puncturing the skin, and although intracranial bleeding is rare, it can cause permanent brain damage or death.
The paused trial is a major effort coordinated by three separate clinical trial groups in several countries, funded jointly by the National Institutes of Health and their counterparts in Canada, Britain, Australia and the European Union.
– .
